Levetiracetam as first‐line monotherapy for Idiopathic Generalized Epilepsy in women

Background Levetiracetam (LEV) is effective in Idiopathic Generalized Epilepsy (IGE) and seems to be a good alternative to valproic acid in women of childbearing age. However, there is lack of approval for this indication as monotherapy. The aim of this study is to assess the efficacy of LEV as a fi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta neurologica Scandinavica 2021-04, Vol.143 (4), p.407-412
Hauptverfasser:	Ballvé, Alejandro, Salas‐Puig, Javier, Quintana, Manuel, Campos, Daniel, Llauradó, Arnau, Raspall, Miquel, Fonseca, Elena, Abraira, Laura, Santamarina, Estevo, Toledo, Manuel
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Anticonvulsants - therapeutic use childbearing Convulsions & seizures Epilepsy Epilepsy, Generalized - diagnosis Epilepsy, Generalized - drug therapy Etiracetam Female Follow-Up Studies genetic generalized epilepsy Humans idiopathic generalized Immunoglobulin E levetiracetam Levetiracetam - therapeutic use Piracetam - therapeutic use Population studies Retrospective Studies Seizures Side effects Treatment Outcome Valproic acid Valproic Acid - therapeutic use women Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!